Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 3 40-3, 1999, Pages

  Murray, Ian ^a   Sniderman, Allan D ^a   Cianflone, Katherine ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Adipose tissue; Complement C3a; Fat load; Free fatty acid; Glucose

Indexed keywords

ACYLATION STIMULATING PROTEIN; COMPLEMENT COMPONENT C3A; FAT; FATTY ACID; GLUCOSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACYLATION; ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; LIPID METABOLISM; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032852072     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.3.e474     Document Type: Article

References (40)

1. Ahren, B., E. Simonsson, A. J. Scheurink, H. Mulder, U. Myrsen, and F. Sundler. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57Bl/6J mice. Metabolism 46: 97-106, 1997.
2. Ailhaud, G., P. Grimaldi, and R. Négrel. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 12: 207-233, 1992.
3. Baldo, A., A. D. Sniderman, S. St.-Luce, R. K. Avramoglu, M. Maslowska, B. Hoang, J. C. Monge, A. Bell, S. Mulay, and K. Cianflone. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Invest. 92: 1543-1547, 1993.
4. Baldo, A., A. D. Sniderman, Z. Yazruel, and K. Cianflone. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J. Lipid Res. 36: 1415-1426, 1995.
5. Bessesen, D. H., C. L. Rupp, and R. H. Eckel. Trafficking of dietary fat in lean rats. Obes. Res. 3: 191-203, 1995.
6. Choy, L. N., B. S. Rosen, and B. M. Spiegelman. Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267: 12736-12741, 1992.
7. Cianflone, K. The acylation stimulating protein pathway: clinical implications. Clin. Biochem. 30: 301-312, 1997.
8. Cianflone, K., D. A. K. Roncari, M. Maslowska, A. Baldo, J. Forden, and A. D. Sniderman. The adipsin-acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 33: 9489-9495, 1994.
9. Cianflone, K., A. D. Sniderman, M. J. Walsh, H. Vu, J. Gagnon, and M. A. Rodriguez. Purification and characterization of acylation stimulating protein. J. Biol. Chem. 264: 426-430, 1989.
10. Cianflone, K., Z. Yasruel, M. A. Rodriguez, D. Vas, and A. D. Sniderman. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 31: 2045-2055, 1990.
11. Eckel, R. H., and D. R. Jensen. Alterations in lipoprotein lipase in insulin resistance. Int. J. Obes. 19, Suppl. 1: S16-S23, 1995.
12. Frayn, K. N., S. Shadid, R. Hamlani, S. M. Humphreys, M. L. Clark, B. A. Fielding, O. Boland, and S. W. Coppack. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E308-E317, 1994.
13. Germinario, R., A. D. Sniderman, S. Manuel, S. Pratt, A. Baldo, and K. Cianflone. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein. Metabolism 40: 574-580, 1993.
14. Hotamisligil, G. S., R. S. Johnson, R. J. Distel, R. Ellis, V. E. Papaioannou, and B. M. Spiegelman. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379, 1996.
15. Hugli, T. E. Anaphylatoxins: C3a and C5a. In: Advances in Immunology, edited by H. G. Kunkle and F. G. Dixon. New York: Academic, 1978, p. 1-53.
16. Kopecký, J., Z. Hodný, M. Rossmeisl, I. Syrový, and L. P. Kozak. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E768-E775, 1996.
17. Lee, K., J. Y. Park, C. H. Kim, S. K. Hong, K. S. Park, and S. W. Park. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats. Metabolism 45: 1408-1414, 1996.
18. Lesavre, P. H., T. E. Hugli, A. F. Esser, and H. J. Muller-Eberhard. The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J. Immunol. 123: 529-534, 1979.
19. Maeda, N. D., H. Li, D. Lee, P. Oliver, S. H. Quarfordt, and J. Osada. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269: 23610-23616, 1994.
20. Maslowska, M., T. Scantlebury, R. Germinario, and K. Cianflone. Acute in vitro production of ASP in differentiated adipocytes. J. Lipid Res. 38: 21-31, 1997.
21. Maslowska, M., A. D. Sniderman, R. Germinario, and K. Cianflone. ASP stimulates glucose transport in cultured human adipocytes. Int. J. Obes. 21: 261-266, 1997.
22. Morin, C. L., R. H. Eckel, T. Marcel, and M. J. Pagliassotti. High fat diets elevate adipose tissue-derived tumor necrosis factor-a activity. Endocrinology 138: 4665-4671, 1997.
23. Muller-Eberhard, H. J., and R. D. Schreiber. Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol. 29: 1-53, 1980.
24. Murray, I., R. A. Parker, T. G. Kirchgessner, J. Tran, Z. J. Zhang, J. Westerlund, and K. Cianflone. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin. J. Lipid Res. 38: 2492-2501, 1997.
25. Pellymounter, M. A., M. J. Cullen, M. B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
26. Peterson, J., B. E. Bihain, G. Bengtsson-Olivecrona, R. J. Deckelbaum, Y. A. Carpentier, and T. Olivecrona. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc. Natl. Acad. Sci. USA 87: 909-913, 1990.
27. Randle, P. J., P. B. Garland, C. N. Hales, and E. A. Newsholme. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I: 785-789, 1963.
28. Randle, P. J., D. A. Priestman, S. C. Mistry, and A. Halsall. Glucose fatty acid interactions and the regulation of glucose disposal. J. of Cell. Biochem. 55, Suppl.: 1-11, 1994.
29. Saleh, J., L. K. M. Summers, K. Cianflone, B. A. Fielding, A. D. Sniderman, and K. N. Frayn. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J. Lipid Res. 39: 884-891, 1998.
30. Saxena, U., L. D. Witte, and I. J. Goldberg. Release of endothelial lipoprotein lipase by plasma lipoproteins and free fatty acids. J. Biol. Chem. 264: 4349-4355, 1989.
31. Scantlebury, T., M. Maslowska, and K. Cianflone. Chylomicron specific enhancement of acylation stimulating protein (ASP) and precursor protein C3 production in differentiated human adipocytes. J. Biol. Chem. 273: 22903-22909, 1998.
32. Shimada, M., H. Shimano, T. Gotoda, K. Yamamoto, M. Kawamura, T. Inaba, and Y. Yazaki. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J. Biol. Chem. 268: 17924-17929, 1993.
33. Sniderman, A. D., and K. Cianflone. The adipsin-acylation stimulating protein pathway and microenvironmental metabolic regulation. In: World Review Nutrition Dietetics, edited by A. Simopoulos and P. Nestel. Basel: Karger, 1996, p. 1-60.
34. Tao, Y. Z., K. Cianflone, A. D. Sniderman, S. P. Colby-Germinario, and R. J. Germinario. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim. Biophys. Acta 1344: 221-229, 1997.
35. Walsh, M. J., A. D. Sniderman, K. Cianflone, H. Vu, M. A. Rodriguez, and R. A. Forse. The effect of ASP on the adipocyte of the morbidly obese. J. Surg. Res. 46: 470-473, 1989.
36. Weinstock, P. H., C. L. Bisgaier, K. Aalto-Setala, H. Radner, R. Ramakrishnan, S. Levakfrank, A. D. Essenburg, R. Zechner, and J. Breslow. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96: 2555-2568, 1995.
37. Yasruel, Z., K. Cianflone, A. D. Sniderman, M. Rosenbloom, M. Walsh, and M. A. Rodriguez. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 26: 495-499, 1991.
38. Yasushi, I., N. Azrolan, A. O'Connell, A. Walsh, and J. L. Breslow. Hypertriglyceridemia as a result of human Apo CIII gene expression in transgenic mice. Science 249: 790-793, 1990.
39. Zechner, R. The tissue-specific expression of lipoprotein lipase: Implications for energy and lipoprotein metabolism. Curr. Opin. Lipidol 8: 77-88, 1997.
40. Zechner, R., R. Moser, T. C. Newman, S. K. Fried, and J. L. Breslow. Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J. Biol. Chem. 266: 10583-10588, 1991.